Opioid antagonist modulation of DNA synthesis in mouse tongue epithelium is circadian dependent

I S Zagon1, Y Wu, P J McLaughlin

  • 1Department of Neuroscience and Anatomy, Pennsylvania State University, College of Medicine, Hershey 17033.

Insights

Endogenous opioids act as growth factors. Blocking opioid receptors with naltrexone (NTX) stimulated epithelial cell renewal in mouse tongues, indicating a role in circadian-dependent cellular renewal.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Physiology

Background:

  • Endogenous opioids are known for neuromodulation.
  • Emerging evidence suggests opioid peptides may also function as growth factors.
  • Their role in epithelial renewal remains largely unexplored.

Purpose of the Study:

  • To investigate the involvement of opioid peptides in epithelial renewal.
  • To determine if disrupting opioid-receptor interactions affects cell proliferation.

Main Methods:

  • Systemic injections of naltrexone (NTX), an opioid antagonist, were administered to mice.
  • The number of basal epithelial cells undergoing DNA synthesis was quantified.
  • Experiments were conducted at different times of day (0700 h and 1700 h).

Main Results:

  • Naltrexone administration significantly increased DNA synthesis in tongue epithelial cells (43-150% above control).
  • This stimulatory effect was observed on the tip, dorsal, and ventral tongue surfaces.
  • The effect was transient, lasting up to 8 hours post-injection, and showed circadian rhythm dependency (present at 1700 h, absent at 0700 h).

Conclusions:

  • This study provides the first evidence that endogenous opioids regulate cellular renewal processes.
  • Opioid peptide involvement in epithelial renewal is dependent on the circadian rhythm.
  • Targeting opioid pathways may offer novel strategies for promoting tissue regeneration.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...